Development and validation of a high-content screening assay to identify inhibitors of cytoplasmic dynein-mediated transport of glucocorticoid receptor to the nucleus
- PMID: 22830992
- PMCID: PMC3464420
- DOI: 10.1089/adt.2012.456
Development and validation of a high-content screening assay to identify inhibitors of cytoplasmic dynein-mediated transport of glucocorticoid receptor to the nucleus
Abstract
Rapid ligand-induced trafficking of glucocorticoid nuclear hormone receptor (GR) from the cytoplasm to the nucleus is an extensively studied model for intracellular retrograde cargo transport employed in constructive morphogenesis and many other cellular functions. Unfortunately, potent and selective small-molecule disruptors of this process are lacking, which has restricted pharmacological investigations. We describe here the development and validation of a 384-well high-content screening (HCS) assay to identify inhibitors of the rapid ligand-induced retrograde translocation of cytoplasmic glucocorticoid nuclear hormone receptor green fluorescent fusion protein (GR-GFP) into the nuclei of 3617.4 mouse mammary adenocarcinoma cells. We selected 3617.4 cells, because they express GR-GFP under the control of a tetracycline (Tet)-repressible promoter and are exceptionally amenable to image acquisition and analysis procedures. Initially, we investigated the time-dependent expression of GR-GFP in 3617.4 cells under Tet-on and Tet-off control to determine the optimal conditions to measure dexamethasone (Dex)-induced GR-GFP nuclear translocation on the ArrayScan-VTI automated imaging platform. We then miniaturized the assay into a 384-well format and validated the performance of the GR-GFP nuclear translocation HCS assay in our 3-day assay signal window and dimethylsulfoxide validation tests. The molecular chaperone heat shock protein 90 (Hsp90) plays an essential role in the regulation of GR steroid binding affinity and ligand-induced retrograde trafficking to the nucleus. We verified that the GR-GFP HCS assay captured the concentration-dependent inhibition of GR-GFP nuclear translocation by 17-AAG, a benzoquinone ansamycin that selectively blocks the binding and hydrolysis of ATP by Hsp90. We screened the 1280 compound library of pharmacologically active compounds set in the Dex-induced GR-GFP nuclear translocation assay and used the multi-parameter HCS data to eliminate cytotoxic compounds and fluorescent outliers. We identified five qualified hits that inhibited the rapid retrograde trafficking of GR-GFP in a concentration-dependent manner: Bay 11-7085, 4-phenyl-3-furoxancarbonitrile, parthenolide, apomorphine, and 6-nitroso-1,2-benzopyrone. The data presented here demonstrate that the GR-GFP HCS assay provides an effective phenotypic screen and support the proposition that screening a larger library of diversity compounds will yield novel small-molecule probes that will enable the further exploration of intracellular retrograde transport of cargo along microtubules, a process which is essential to the morphogenesis and function of all cells.
Figures

















Similar articles
-
Characterization of inhibitors of glucocorticoid receptor nuclear translocation: a model of cytoplasmic dynein-mediated cargo transport.Assay Drug Dev Technol. 2012 Feb;10(1):46-60. doi: 10.1089/adt.2010.0367. Epub 2011 Sep 15. Assay Drug Dev Technol. 2012. PMID: 21919741 Free PMC article.
-
Retrograde transport of the glucocorticoid receptor in neurites requires dynamic assembly of complexes with the protein chaperone hsp90 and is linked to the CHIP component of the machinery for proteasomal degradation.Brain Res Mol Brain Res. 2004 Apr 7;123(1-2):27-36. doi: 10.1016/j.molbrainres.2003.12.015. Brain Res Mol Brain Res. 2004. PMID: 15046863
-
Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton.Mol Endocrinol. 1998 Dec;12(12):1903-13. doi: 10.1210/mend.12.12.0204. Mol Endocrinol. 1998. PMID: 9849964
-
Chaperoning of glucocorticoid receptors.Handb Exp Pharmacol. 2006;(172):111-38. doi: 10.1007/3-540-29717-0_5. Handb Exp Pharmacol. 2006. PMID: 16610357 Review.
-
Modulatory effects of L-carnitine on glucocorticoid receptor activity.Ann N Y Acad Sci. 2004 Nov;1033:147-57. doi: 10.1196/annals.1320.014. Ann N Y Acad Sci. 2004. PMID: 15591012 Review.
Cited by
-
Development and Implementation of a High-Throughput High-Content Screening Assay to Identify Inhibitors of Androgen Receptor Nuclear Localization in Castration-Resistant Prostate Cancer Cells.Assay Drug Dev Technol. 2016 May;14(4):226-39. doi: 10.1089/adt.2016.716. Assay Drug Dev Technol. 2016. PMID: 27187604 Free PMC article.
-
High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.Assay Drug Dev Technol. 2014 Jan-Feb;12(1):55-79. doi: 10.1089/adt.2013.524. Epub 2013 Oct 15. Assay Drug Dev Technol. 2014. PMID: 24127660 Free PMC article.
-
High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.Assay Drug Dev Technol. 2014 Sep;12(7):395-418. doi: 10.1089/adt.2014.594. Assay Drug Dev Technol. 2014. PMID: 25181412 Free PMC article.
-
High-Content Screening Comparison of Cancer Drug Accumulation and Distribution in Two-Dimensional and Three-Dimensional Culture Models of Head and Neck Cancer.Assay Drug Dev Technol. 2018 Jan;16(1):27-50. doi: 10.1089/adt.2017.812. Epub 2017 Dec 7. Assay Drug Dev Technol. 2018. PMID: 29215913 Free PMC article.
-
High Content Imaging Assays for IL-6-Induced STAT3 Pathway Activation in Head and Neck Cancer Cell Lines.Methods Mol Biol. 2018;1683:229-244. doi: 10.1007/978-1-4939-7357-6_14. Methods Mol Biol. 2018. PMID: 29082496 Free PMC article.
References
-
- Hirokawa N. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science. 1998;279:519–526. - PubMed
-
- Hirokawa N. Noda Y. Tanaka Y. Niwa S. Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol. 2009;10:682–696. - PubMed
-
- Vallee R. Williams JC. Varma D. Barnhart LE. Dynein: an ancient motor protein involved in multiple modes of transport. J Neurobiol. 2003;58:189–200. - PubMed
-
- Vallee R. Höök P. Autoinhibitory and other autoregulatory elements within the dynein motor domain. J Struct Biol. 2006;156:175–181. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources